Fraunhofer Center for Molecular Biotechnology (FhCMB) is a division of Fraunhofer USA, Inc., a not-for-profit, research organization, whose mission is to develop safe and effective vaccines and therapeutics targeting infectious diseases and autoimmune disorders. Our 56,000 square foot research and development facility also houses a state of the art, cGMP pilot facility which uses our unique, plant-based technology to produce proteins. Two clinical trials are currently underway.
In The News
July 26, 2017
Innovation Delaware Company to Watch: Prelude Therapeutics from a textbook or a lesson plan. “Discovery is an art,” Vaddi says. “It’s not something that’s taught.” As Vaddi’s latest business venture, Prelude Therapeutics, finds its way forward, he hopes to be …
February 22, 2017
The Delaware Small Business Development Center has prevented about 600 former DuPont workers from leaving Delaware to pursue jobs in other states, said J. Michael Bowman, the organization’s director. Bowman made the remarks Tuesday afternoon at a hearing before the …